GILD logo Gilead Sciences +
Gilead Sciences
+

Gilead Sciences's Revenue (2016 - 2025)

  • Gilead Sciences's annual revenue was $29.44 B in fiscal year 2025. The annual revenue increased $689.00 M from $28.75 B (in 2024) to $29.44 B (in 2025), representing a 2.40% year-over-year growth.

  • Gilead Sciences's quarterly revenue was $6.96 B in the quarter ending Mar 2026. The quarterly revenue increased $293.00 M from $6.67 B (in Q1: Dec 2025) to $6.96 B (in Q1: Dec 2026), representing a 4.39% year-over-year growth.

    • Over the past 10 years (2016 - 2025):
  • The highest annual revenue for Gilead Sciences was $30.39 B in fiscal year 2016.
  • The lowest annual revenue was $22.13 B in fiscal year 2018.
  • The average revenue was $26.57 B.

    • Learn more about Gilead Sciences's Revenue by Segment and Revenue by Region.

    Check out competitors to Gilead Sciences in a side-by-side comparison.

    Explore additional financial metrics for Gilead Sciences.


    Definition of Revenue :
  • Revenue is the amount of money generated by a business from sales of its goods or services. Refer to our glossary for more details, examples, and formulas.
Continue reading...

Gilead Sciences's Revenue Trend

2025

Gilead Sciences's annual revenue was $29.44 B in fiscal year 2025.

Gilead Sciences's quarterly revenue was $6.67 B(Q1: Mar 2025), $7.08 B(Q2: Jun 2025), $7.77 B(Q3: Sep 2025), $7.93 B(Q4: Dec 2025) in fiscal year 2025.

2024

Gilead Sciences's annual revenue was $28.75 B in fiscal year 2024.

Gilead Sciences's quarterly revenue was $6.69 B(Q1: Mar 2024), $6.95 B(Q2: Jun 2024), $7.55 B(Q3: Sep 2024), $7.57 B(Q4: Dec 2024) in fiscal year 2024.

2023

Gilead Sciences's annual revenue was $27.12 B in fiscal year 2023.

Gilead Sciences's quarterly revenue was $6.35 B(Q1: Mar 2023), $6.60 B(Q2: Jun 2023), $7.05 B(Q3: Sep 2023), $7.11 B(Q4: Dec 2023) in fiscal year 2023.

2022

Gilead Sciences's annual revenue was $27.28 B in fiscal year 2022.

Gilead Sciences's quarterly revenue was $6.59 B(Q1: Mar 2022), $6.26 B(Q2: Jun 2022), $7.04 B(Q3: Sep 2022), $7.39 B(Q4: Dec 2022) in fiscal year 2022.

2021

Gilead Sciences's annual revenue was $27.31 B in fiscal year 2021.

Gilead Sciences's quarterly revenue was $6.42 B(Q1: Mar 2021), $6.22 B(Q2: Jun 2021), $7.42 B(Q3: Sep 2021), $7.24 B(Q4: Dec 2021) in fiscal year 2021.

2020

Gilead Sciences's annual revenue was $24.69 B in fiscal year 2020.

Gilead Sciences's quarterly revenue was $5.55 B(Q1: Mar 2020), $5.14 B(Q2: Jun 2020), $6.58 B(Q3: Sep 2020), $7.42 B(Q4: Dec 2020) in fiscal year 2020.

2019

Gilead Sciences's annual revenue was $22.45 B in fiscal year 2019.

Gilead Sciences's quarterly revenue was $5.28 B(Q1: Mar 2019), $5.69 B(Q2: Jun 2019), $5.60 B(Q3: Sep 2019), $5.88 B(Q4: Dec 2019) in fiscal year 2019.

2018

Gilead Sciences's annual revenue was $22.13 B in fiscal year 2018.

Gilead Sciences's quarterly revenue was $5.09 B(Q1: Mar 2018), $5.65 B(Q2: Jun 2018), $5.60 B(Q3: Sep 2018), $5.80 B(Q4: Dec 2018) in fiscal year 2018.

2017

Gilead Sciences's annual revenue was $26.11 B in fiscal year 2017.

Gilead Sciences's quarterly revenue was $6.51 B(Q1: Mar 2017), $7.14 B(Q2: Jun 2017), $6.51 B(Q3: Sep 2017), $5.95 B(Q4: Dec 2017) in fiscal year 2017.

2016

Gilead Sciences's annual revenue was $30.39 B in fiscal year 2016.

Gilead Sciences's quarterly revenue was $7.79 B(Q1: Mar 2016), $7.78 B(Q2: Jun 2016), $7.50 B(Q3: Sep 2016), $7.32 B(Q4: Dec 2016) in fiscal year 2016.

Continue reading...

Gilead Sciences's Revenue (Year-over-Year Change)

2015 0
2016 -6.89
2017 -14.09
2018 -15.24
2019 +1.46
2020 +9.98
2021 +10.60
2022 -0.09
2023 -0.60
2024 +6.04
2025 +2.40

2025

Gilead Sciences’s annual revenue increased +2.40% during fiscal year 2025 compared to 2024. It represents a growth of $689.00 M from $28.75 B (in 2024) to $29.44 B (in 2025).

2024

Gilead Sciences’s annual revenue increased +6.04% during fiscal year 2024 compared to 2023. It represents a growth of $1.64 B from $27.12 B (in 2023) to $28.75 B (in 2024).

2023

Gilead Sciences’s annual revenue decreased -0.60% during fiscal year 2023 compared to 2022. It represents a decline of $165.00 M from $27.28 B (in 2022) to $27.12 B (in 2023).

2022

Gilead Sciences’s annual revenue decreased -0.09% during fiscal year 2022 compared to 2021. It represents a decline of $24.00 M from $27.31 B (in 2021) to $27.28 B (in 2022).

2021

Gilead Sciences’s annual revenue increased +10.60% during fiscal year 2021 compared to 2020. It represents a growth of $2.62 B from $24.69 B (in 2020) to $27.31 B (in 2021).

2020

Gilead Sciences’s annual revenue increased +9.98% during fiscal year 2020 compared to 2019. It represents a growth of $2.24 B from $22.45 B (in 2019) to $24.69 B (in 2020).

2019

Gilead Sciences’s annual revenue increased +1.46% during fiscal year 2019 compared to 2018. It represents a growth of $322.00 M from $22.13 B (in 2018) to $22.45 B (in 2019).

2018

Gilead Sciences’s annual revenue decreased -15.24% during fiscal year 2018 compared to 2017. It represents a decline of $3.98 B from $26.11 B (in 2017) to $22.13 B (in 2018).

2017

Gilead Sciences’s annual revenue decreased -14.09% during fiscal year 2017 compared to 2016. It represents a decline of $4.28 B from $30.39 B (in 2016) to $26.11 B (in 2017).

2016

Gilead Sciences’s annual revenue decreased -6.89% during fiscal year 2016 compared to 2015. It represents a decline of $2.25 B from $32.64 B (in 2015) to $30.39 B (in 2016).

Continue reading...

Gilead Sciences Revenue History

Sign in to download table

Period Revenue Year-over-Year Change
FY 2025
$29.44 B $689.00 M 2.4%
Q4: Dec 25 $7.93 B $356.00 M 4.7%
Q3: Sep 25 $7.77 B $224.00 M 2.97%
Q2: Jun 25 $7.08 B $128.00 M 1.84%
Q1: Mar 25 $6.67 B -$19.00 M 0.28%
FY 2024
$28.75 B $1.64 B 6.04%
Q4: Dec 24 $7.57 B $455.00 M 6.4%
Q3: Sep 24 $7.55 B $495.00 M 7.02%
Q2: Jun 24 $6.95 B $354.00 M 5.36%
Q1: Mar 24 $6.69 B $334.00 M 5.26%
FY 2023
$27.12 B -$165.00 M 0.6%
Q4: Dec 23 $7.11 B -$275.00 M 3.72%
Q3: Sep 23 $7.05 B $8.00 M 0.11%
Q2: Jun 23 $6.60 B $339.00 M 5.42%
Q1: Mar 23 $6.35 B -$238.00 M 3.61%
FY 2022
$27.28 B -$24.00 M 0.09%
Q4: Dec 22 $7.39 B $145.00 M 2%
Q3: Sep 22 $7.04 B -$379.00 M 5.11%
Q2: Jun 22 $6.26 B $43.00 M 0.69%
Q1: Mar 22 $6.59 B $167.00 M 2.6%
FY 2021
$27.31 B $2.62 B 10.6%
Q4: Dec 21 $7.24 B -$177.00 M 2.39%
Q3: Sep 21 $7.42 B $844.00 M 12.83%
Q2: Jun 21 $6.22 B $1.07 B 20.88%
Q1: Mar 21 $6.42 B $875.00 M 15.77%
FY 2020
$24.69 B $2.24 B 9.98%
Q4: Dec 20 $7.42 B $1.54 B 26.23%
Q3: Sep 20 $6.58 B $973.00 M 17.36%
Q2: Jun 20 $5.14 B -$542.00 M 9.53%
Q1: Mar 20 $5.55 B $267.00 M 5.06%
FY 2019
$22.45 B $322.00 M 1.46%
Q4: Dec 19 $5.88 B $84.00 M 1.45%
Q3: Sep 19 $5.60 B $8.00 M 0.14%
Q2: Jun 19 $5.69 B $37.00 M 0.66%
Q1: Mar 19 $5.28 B $193.00 M 3.79%
FY 2018
$22.13 B -$3.98 B 15.24%
Q4: Dec 18 $5.80 B -$154.00 M 2.59%
Q3: Sep 18 $5.60 B -$916.00 M 14.07%
Q2: Jun 18 $5.65 B -$1.49 B 20.91%
Q1: Mar 18 $5.09 B -$1.42 B 21.78%
FY 2017
$26.11 B -$4.28 B 14.09%
Q4: Dec 17 $5.95 B -$1.37 B 18.73%
Q3: Sep 17 $6.51 B -$988.00 M 13.17%
Q2: Jun 17 $7.14 B -$635.00 M 8.17%
Q1: Mar 17 $6.51 B -$1.29 B 16.54%
FY 2016
$30.39 B -$2.25 B 6.89%
Q4: Dec 16 $7.32 B -$1.19 B 13.94%
Q3: Sep 16 $7.50 B -$795.00 M 9.58%
Q2: Jun 16 $7.78 B -$468.00 M 5.68%
Q1: Mar 16 $7.79 B $200.00 M 2.63%

Frequently Asked Questions

What is the annual revenue of Gilead Sciences?

In fiscal year 2025, Gilead Sciences's revenue was $29.44 Billion.

How much did Gilead Sciences's revenue change in the last year?

Gilead Sciences's revenue increased by +2.40% (+$689.00 Million) in 2025 compared to 2024.

What is Gilead Sciences's most recent quarterly revenue?

In the first quarter (Q1) of 2026, Gilead Sciences reported a revenue of $6.96 Billion.

What is Gilead Sciences's revenue per share (TTM)?

Gilead Sciences's revenue per share over the trailing twelve months is $23.94.

What is Gilead Sciences's revenue per employee?

In the fiscal year 2025, Gilead Sciences's revenue per employee was $1.73 Million.

What is the annual net income of Gilead Sciences?

In fiscal year 2025, Gilead Sciences's net income was $8.51 Billion.

What is Gilead Sciences's biggest product segment, and what is its revenue?

Products, Other HIV is Gilead Sciences's biggest product segment, generating $20.75 Billion in revenue for fiscal year 2025.

What is Gilead Sciences's net income per employee?

In the fiscal year 2025, Gilead Sciences's net income per employee was $500.59 K.

Related

People Also Search For

Submit feedback to Bullfincher